A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs (AMPLIFY)

Kirby Institute

Status: Unknown

Conditions: Hepatitis C, Chronic

Treatments: Behavioral: Incentive payment

Study type: Interventional

Funder types: Other

Identifiers

NCT04428346

VHCRP2004

Details and patient eligibility

About

A pilot two-arm, individual-level, randomised controlled trial to assess the effect of an intervention integrating contingency management (financial incentives) to enhance hepatitis C treatment uptake following dried blood spot hepatitis C RNA testing among people with recent injecting drug use attending needle and syringe programs: the AMPLIFY study

Enrollment: 400 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Participants have voluntarily signed the informed consent form
2. 18 years of age or older
3. Recent injecting drug use (previous six months)

Exclusion criteria

1. Inability or unwillingness to provide informed consent

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

400 participants in 2 patient groups

Contigency Management (Intervention)

Active Comparator group

Treatment:

Behavioral: Incentive payment

Standard of Care (Control)

No Intervention group